Helen M. Thackray Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Helen M. Thackray.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Helen M. Thackray. Helen M. Thackray is Chief R&D Officer in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and SVP Clinical Development, CMO in GLYCOMIMETICS INC ($GLYC) and VP Clinical Development, CMO in GLYCOMIMETICS INC ($GLYC).
Latest Insider Trading Transactions of Helen M. Thackray
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | BCRX | BIOCRYST PHARMACEU ... | Thackray Helen M. | Chief R&D Officer | Option Exercise | A | 10.17 | 400,000 | 4,068,000 | 400,000 | |
| Apr 02 2021 | BCRX | BIOCRYST PHARMACEU ... | Thackray Helen M. | Chief R&D Officer | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Option Exercise | A | 3.81 | 69,000 | 262,890 | 69,000 | |
| Jan 22 2021 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Grant | A | 0.00 | 34,500 | 0 | 183,115 | 148.6 K to 183.1 K (+23.21 %) |
| May 14 2020 | BCRX | BIOCRYST PHARMACEU ... | Thackray Helen M. | Director | Option Exercise | A | 5.41 | 40,000 | 216,400 | 40,000 | |
| Jan 24 2020 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Option Exercise | A | 4.72 | 120,000 | 566,400 | 120,000 | |
| Sep 24 2019 | BCRX | BIOCRYST PHARMACEU ... | Thackray Helen M. | Director | Option Exercise | A | 2.86 | 40,000 | 114,400 | 40,000 | |
| Jan 22 2019 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Option Exercise | A | 10.59 | 100,000 | 1,059,000 | 100,000 | |
| Jan 12 2018 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Option Exercise | A | 20.03 | 75,000 | 1,502,250 | 75,000 | |
| Dec 12 2017 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Sell | S | 15.01 | 2,000 | 30,020 | 148,615 | 150.6 K to 148.6 K (-1.33 %) |
| Sep 18 2017 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Sell | S | 13.00 | 2,000 | 26,000 | 150,615 | 152.6 K to 150.6 K (-1.31 %) |
| May 30 2017 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Sell | S | 15.57 | 2,000 | 31,140 | 152,615 | 154.6 K to 152.6 K (-1.29 %) |
| May 22 2017 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Sell | S | 12.14 | 2,000 | 24,280 | 154,615 | 156.6 K to 154.6 K (-1.28 %) |
| Jan 05 2017 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | SVP Clinical Develo ... | Option Exercise | A | 6.33 | 75,000 | 474,750 | 75,000 | |
| Oct 04 2016 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Sell | S | 7.01 | 100 | 701 | 156,615 | 156.7 K to 156.6 K (-0.06 %) |
| Oct 04 2016 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Sell | S | 7.00 | 3,900 | 27,300 | 156,715 | 160.6 K to 156.7 K (-2.43 %) |
| Jul 21 2016 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Sell | S | 8.00 | 2,000 | 16,000 | 160,615 | 162.6 K to 160.6 K (-1.23 %) |
| Jul 06 2016 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Sell | S | 6.68 | 6,796 | 45,397 | 162,615 | 169.4 K to 162.6 K (-4.01 %) |
| Jul 06 2016 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Sell | S | 7.01 | 10,136 | 71,053 | 169,411 | 179.5 K to 169.4 K (-5.65 %) |
| Jul 06 2016 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Sell | S | 7.40 | 5,068 | 37,503 | 179,547 | 184.6 K to 179.5 K (-2.75 %) |
| Jan 11 2016 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Option Exercise | A | 5.22 | 71,000 | 370,620 | 71,000 | |
| Jan 12 2015 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Option Exercise | A | 7.15 | 71,000 | 507,650 | 71,000 | |
| Jan 13 2014 | GLYC | GLYCOMIMETICS INC | Thackray Helen M. | VP Clinical Develop ... | Option Exercise | A | 8.00 | 112,692 | 901,536 | 112,692 |
Page: 1